Gene therapies for preserving and prolonging muscle health
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
196
NCT04839042
A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 28, 2021
Completion: Mar 4, 2025
Loading map...